{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T14:46:29Z","timestamp":1760798789755,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intensive and Critical Care Nursing"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.iccn.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T12:17:25Z","timestamp":1213359445000},"page":"260-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tigecycline: A new antibiotic"],"prefix":"10.1016","volume":"24","author":[{"given":"Jane","family":"Hylands","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccn.2008.03.006_bib1","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/AAC.49.11.4658-4666.2005","article-title":"Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double blind phase 3 comparison study with vancomycin and aztreonam","volume":"49","author":"Breedt","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.iccn.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijsu.2005.03.011","article-title":"Tigecycline is efficacious in the treatment of complicated intra-abdominal infections","volume":"3","author":"Formin","year":"2005","journal-title":"International Journal of Surgery"},{"key":"10.1016\/j.iccn.2008.03.006_bib3","unstructured":"Olivia ME, Rekha A, Yellin A. et al. A muticentre trial of the efficacy and safety of tigecycline versus imipenem\/cilastatin in patients with complicated intra-abdominal infections. BMC Infectious Diseases 2005; 5:88. Available at www.biomedcentral.com\/1471-2334-5-88."},{"key":"10.1016\/j.iccn.2008.03.006_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijid.2005.05.003","article-title":"Effiacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam on patients with complicated skin and skin structure infections: results from a phase 3, randomised, double blind trial","volume":"9","author":"Sacchidanand","year":"2005","journal-title":"International Journal of Infectious diseases"},{"key":"10.1016\/j.iccn.2008.03.006_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diagmicrobio.2005.05.002","article-title":"Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalised in the intensive care unit","volume":"52","author":"Sader","year":"2005","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"10.1016\/j.iccn.2008.03.006_bib6","unstructured":"Summary of Product Characteristics-Tygacil\u2122. Wyeth Pharmaceuticals. May, 2006."}],"container-title":["Intensive and Critical Care Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096433970800030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096433970800030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T14:23:01Z","timestamp":1760797381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096433970800030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S096433970800030X"],"URL":"https:\/\/doi.org\/10.1016\/j.iccn.2008.03.006","relation":{},"ISSN":["0964-3397"],"issn-type":[{"type":"print","value":"0964-3397"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tigecycline: A new antibiotic","name":"articletitle","label":"Article Title"},{"value":"Intensive and Critical Care Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccn.2008.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}